Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 383

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 383
---
 53 |     |         61 |
|                                               |     |        720 |     |        742 |     |        746 |

During the year no
Directors (2022: 0; 2012: 1) participated in a defined contribution pension scheme. Pension contributions in the above note include
those of the Chief Scientific Officer.

Emoluments disclosed above include the following
amounts in respect of the highest paid Director.

| Schedule of emoluments       
 disclosed                    |     |            |     |            |     |            |
|                              |     | 2023 £’000 |     | 2022 £’000 |     | 2021 £’000 |
| Short term employee benefits |     |        252 |     |        238 |     |        223 |
| Post-employment benefits     |     |          – |     |          – |     |         11 |
|                              |     |        252 |     |        238 |     |        234 |

None of the Directors
have exercised share options during the year (2022: nil, 2021: nil).

| F-44 |

| 6 | Finance income and expense |

| Schedule of finance income                            |     |            |     |            |     |            |
|                                                       |     | 2023 £’000 |     | 2022 £’000 |     | 2021 £’000 |
| Finance income                                        |     |            |     |            |     |            |
| Interest received on bank deposits                    |     |         73 |     |         29 |     |          – |
| Other interest receivable                             |     |         10 |     |          – |     |          – |
| Gain on equity settled derivative financial liability |     |        487 |     |        468 |     |        936 |
| Total finance income                                  |     |        570 |     |        497 |     |        936 |

|                                       |     | 2023 £’000 |     | 2022 £’000 |     | 2021 £’000 |
| Finance expense                       |     |            |     |            |     |            |
| Interest expense on lease liabilities |     |         28 |     |         43 |     |         36 |
| Other loans                           |     |         13 |     |         10 |     |          8 |
|